Next Article in Journal
A Review of Protein-Based COVID-19 Vaccines: From Monovalent to Multivalent Formulations
Next Article in Special Issue
Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine
Previous Article in Journal
Protective Efficacy of a Novel DNA Vaccine with a CL264 Molecular Adjuvant against Toxoplasma gondii in a Murine Model
 
 
Article

Article Versions Notes

Vaccines 2024, 12(6), 578; https://doi.org/10.3390/vaccines12060578
Action Date Notes Link
article xml file uploaded 25 May 2024 11:02 CEST Original file -
article xml uploaded. 25 May 2024 11:02 CEST Update https://www.mdpi.com/2076-393X/12/6/578/xml
article pdf uploaded. 25 May 2024 11:02 CEST Version of Record https://www.mdpi.com/2076-393X/12/6/578/pdf
article supplementary file uploaded. 25 May 2024 11:02 CEST - https://www.mdpi.com/2076-393X/12/6/578#supplementary
article html file updated 25 May 2024 11:04 CEST Original file https://www.mdpi.com/2076-393X/12/6/578/html
Back to TopTop